MedPath

Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity

Conditions
Ketosis
Lysosomal Acid Lipase Deficiency
Obesity
Ketogenic Dieting
Registration Number
NCT03564002
Lead Sponsor
University Of Perugia
Brief Summary

The very low carbohydrates diet (VLCKD) induces liver steatosis amelioration. Lysosomal acid lipase (LAL) deficiency plays a role in fats accumulation in liver. To date, no studies have assessed LAL activity in morbid obesity. The aim of our study is to evaluate VLCKD impact on metabolic/vascular parameters and LAL activity in obese patients.

A VLCKD is administered for 25 days to 52 morbid obese patients (BMI 44.7±8.3 kg/m², age 49±12.5 years); at baseline and after diet we evaluated: BMI, glyco-lipidic pattern, abdominal ultrasonography (liver steatosis and visceral fat area) and flow-mediated dilation (FMD). In a subgroup of 20 patients we also tested lysosomal acid lipase (LAL)-activity. A group of healthy normal weight subjects (age 43±13, BMI 22.8±2.6 kg/m²) was also included in the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • BMI > 40 Kg/m2 or > 35 kg/m2 with comorbidities
Exclusion Criteria
  • Type-2 diabetes
  • Kidney, heart or liver failure

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
lysosomal acid lipase activitychange from baseline after 25 days

LAL-activity was dosed with dried blood spot (DBS) technique using the inhibitors Lalistat 2

general adiposity assessmentchange from baseline after 25 days

bioimpedentiometry

endothelial functionchange from baseline after 25 days

flow mediated dilation at brachial artery by ultrasonography

visceral fatchange from baseline after 25 days

ultrasonography

liver steatosischange from baseline after 25 days

ultrasonography

lipid assessmentchange from baseline after 25 days

total cholesterol, triglycerides, HDL, LDL

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Perugia

🇮🇹

Perugia, Italy

© Copyright 2025. All Rights Reserved by MedPath